PERIACTIN Side Effects

5615232-4 | Depression, Dizziness, Faeces Pale, Fall, Formication, Hepatocellular Injury, Loss Of Libido, Pruritus
on Feb 05, 2008 Female patient from UNITED STATES , 50 years of age, weighting 160.0 lb, was diagnosed with migraine prophylaxis and was treated with Periactin (View Usage). Patient experienced the following unwanted or unexpected effects: depression (What is depression?), dizziness (What is dizziness?), faeces pale, fall (What is fall?), formication, hepatocellular injury, loss of libido, pruritus. Periactin dosage: Small Initial Doses Daily Po. During the same period patient was treated with DEPAKOTE (View Depakote Review and Depakote Label ), NEURONTIN (View Neurontin Review and Neurontin Label ).

5520231-7 | Anticholinergic Syndrome, Delirium
Patient was taking Periactin (View Usage). Patient had the following side effects: anticholinergic syndrome, delirium on Nov 08, 2007 from AUSTRALIA Additional patient health information: Female patient , 14 years of age, weighting 90.39 lb, was diagnosed with migraine (What is migraine?), depression (What is depression?) and. Periactin dosage: . During the same period patient was treated with PROMETHAZINE (View Promethazine Review and Promethazine Label ), FLUVOXAMINE MALEATE (View Fluvoxamine Maleate Review and Fluvoxamine Maleate Label ). Patient was hospitalized.

5518390-5 | Hypothermia
Adverse event was reported on Nov 08, 2007 by a Female patient taking Periactin (View Usage) (Dosage: ) was diagnosed with rhinorrhoea, bronchitis (What is bronchitis?), cough, sputum retention, tracheal disorder and. Location: JAPAN , child 2 years of age, weighting 26.46 lb, After Periactin was administered, patient had the following side effects: hypothermia (What is hypothermia?). During the same period patient was treated with CLARITHROMYCIN (View Clarithromycin Review and Clarithromycin Label ), ASVERIN (View Asverin Review and Asverin Label ), MUCODYNE (View Mucodyne Review and Mucodyne Label ), TULOBUTEROL HYDROCHLORIDE (View Tulobuterol Hydrochloride Review and Tulobuterol Hydrochloride Label ).

5507801-7 | Body Temperature Decreased
on Oct 26, 2007 Female patient from JAPAN , child 2 years of age, weighting 26.46 lb, was diagnosed with nasopharyngitis, bronchitis (What is bronchitis?) and was treated with Periactin (View Usage). Patient experienced the following unwanted or unexpected effects: body temperature decreased. Periactin dosage: . During the same period patient was treated with CLARITHROMYCIN (View Clarithromycin Review and Clarithromycin Label ), ASVERIN (View Asverin Review and Asverin Label ), MUCODYNE (View Mucodyne Review and Mucodyne Label ), TULOBUTEROL HYDROCHLORIDE (View Tulobuterol Hydrochloride Review and Tulobuterol Hydrochloride Label ).


5445636-4 | Anticholinergic Syndrome, Delirium
on Aug 30, 2007 Female patient from AUSTRALIA , 14 years of age, weighting 90.39 lb, was diagnosed with migraine (What is migraine?), depression (What is depression?) and was treated with Periactin (View Usage). Patient had the following side effects: anticholinergic syndrome, delirium. Periactin dosage: . During the same period patient was treated with PROMETHAZINE (View Promethazine Review and Promethazine Label ), FLUVOXAMINE MALEATE (View Fluvoxamine Maleate Review and Fluvoxamine Maleate Label ). Patient was hospitalized.

4595861-X | Feeling Abnormal, Flat Affect, Insomnia
Patient was taking Periactin (View Usage). After Periactin was administered, patient had the following side effects: feeling abnormal, flat affect, insomnia on Feb 24, 2005 from Additional patient health information: Female patient , 22 years of age, weighting 122.0 lb, . Periactin dosage: .

4570928-0 | Depressed Level Of Consciousness, Overdose, Somnolence
Adverse event was reported on Dec 24, 2004 by a Male patient taking Periactin (View Usage) (Dosage: ) was diagnosed with rhinorrhoea, sputum retention, asthma (What is asthma?), anaemia and. Location: , weighting 19.84 lb, Patient experienced the following unwanted or unexpected effects: depressed level of consciousness, overdose, somnolence. During the same period patient was treated with ASVERIN (View Asverin Review and Asverin Label ), MUCODYNE (View Mucodyne Review and Mucodyne Label ), MUCOSOLVAN (View Mucosolvan Review and Mucosolvan Label ), POLARAMINE (View Polaramine Review and Polaramine Label ), THEO DUR (View Theo-dur Review and Theo-dur Label ), HOKUNALIN (View Hokunalin Review and Hokunalin Label ). Patient was hospitalized.

4567453-X | Depressed Level Of Consciousness
on Jan 26, 2005 Male patient from , child 5 years of age, weighting 44.09 lb, was diagnosed with upper respiratory tract inflammation, epilepsy (What is epilepsy?) and was treated with Periactin (View Usage). Patient had the following side effects: depressed level of consciousness. Periactin dosage: . During the same period patient was treated with CLONAZEPAM (View Clonazepam Review and Clonazepam Label ). Patient was hospitalized.

4560597-8 | Depressed Level Of Consciousness, Somnolence
on Dec 24, 2004 Male patient from , weighting 19.84 lb, was diagnosed with rhinorrhoea, sputum retention, bronchiectasis, anaemia and was treated with Periactin (View Usage). After Periactin was administered, patient had the following side effects: depressed level of consciousness, somnolence. Periactin dosage: . During the same period patient was treated with ASVERIN (View Asverin Review and Asverin Label ), MUCODYNE (View Mucodyne Review and Mucodyne Label ), MUCOSOLVAN (View Mucosolvan Review and Mucosolvan Label ), POLARAMINE (View Polaramine Review and Polaramine Label ), THEO DUR (View Theo-dur Review and Theo-dur Label ), HOKUNALIN (View Hokunalin Review and Hokunalin Label ). Patient was hospitalized.

4547728-0 | Ascites, Cerebrospinal Fluid Leakage
Patient was taking Periactin (View Usage). Patient experienced the following unwanted or unexpected effects: ascites, cerebrospinal fluid leakage on Dec 22, 2004 from Additional patient health information: Male patient , child 5 years of age, . Periactin dosage: . Patient was hospitalized.